moxonidine has been researched along with Hypertension, Renal in 3 studies
moxonidine: structure given in first source
Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic hypertension often accompanies chronic renal failure and can accelerate its progression to end-stage renal disease (ESRD)." | 2.73 | Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis. ( Baum, D; Greiner, W; Littlewood, KJ; Zoellner, Y, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vonend, O | 1 |
| Marsalek, P | 1 |
| Russ, H | 1 |
| Wulkow, R | 1 |
| Oberhauser, V | 1 |
| Rump, LC | 1 |
| Kotanko, P | 1 |
| Littlewood, KJ | 1 |
| Greiner, W | 1 |
| Baum, D | 1 |
| Zoellner, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Renal Denervation on Blood Pressure in Patients With Chronic Kidney Disease and Uncontrolled Hypertension[NCT04264403] | 44 participants (Actual) | Interventional | 2020-01-23 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for moxonidine and Hypertension, Renal
| Article | Year |
|---|---|
Cause and consequences of sympathetic hyperactivity in chronic kidney disease.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Brain | 2006 |
2 trials available for moxonidine and Hypertension, Renal
| Article | Year |
|---|---|
Moxonidine treatment of hypertensive patients with advanced renal failure.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Creatinine; Disease Progression; Female; Human | 2003 |
Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis.
Topics: Antihypertensive Agents; Cost-Benefit Analysis; Disease Progression; Humans; Hypertension, Renal; Im | 2007 |